Artificial Intelligence (AI) in Life Sciences Market
| 出版社 | BCC Research |
| 出版年月 | 2024年8月 |
| ページ数 | 100 |
| 図表数 | 90 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 5,500 |
| 種別 | 英文調査報告書 |
当レポートはライフサイエンスにおける人工知能(AI)市場の調査・分析を行ったBCC Researchの市場調査報告書です。
Report Overview
Report Scope:
This report aims to comprehensively study the market size of global artificial intelligence (AI) in the life sciences. Current and historical market revenues can be estimated based on products, applications, end users, and regions.
Report Includes:
– 26 data tables and 35 additional tables
– Analyses of trends in the global market for AI in life sciences, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
– Estimates of the current market size and revenue prospects, along with a market share analysis based on product segment, application, end user and region
– Facts and figures pertaining to the market dynamics, current and emerging technologies, regulatory scenario and the expected impact of macroeconomic factors
– Identification of the AI products and technologies with the highest commercial potential, and their relevant applications in life sciences, specifically precision medicine and personalized healthcare
– Overview of ESG developments and sustainability trends, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
– Review of patent activity and key patent grants
– An analysis of the industry structure, including companies’ market shares, merger and acquisition activity, and venture funding outlook
– Profiles of the leading companies, including AiCure LLC., Apixio Inc., Atomwise Inc., BenevolentAI and NuMedii Inc.
Report Synopsis
| Report Metrics | Details | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||
| Forecast period considered | 2024-2029 | ||||||||
| Base year market size | $8.0 Billion | ||||||||
| Market size forecast | $33.5 Billion | ||||||||
| Growth rate | CAGR of 27.9% from 2024 to 2029 | ||||||||
| Units considered | $ Millions | ||||||||
| Segments covered | By Product Segment, Application, End User, and Region | ||||||||
| Regions covered | North America, Europe, Asia-Pacific, and the Rest of the World (RoW) | ||||||||
| Key Market Drivers |
| ||||||||
| Companies studied |
|
Executive Summary
Summary:
The global market for artificial intelligence (AI) in life sciences was $8.0 billion in 2023. Mass spectrometry technology innovation and biomarker development are helping the market grow,
and it is expected to reach $33.5 billion by the end of 2029. The market is forecast to grow at a CAGR of 27.9% from 2024 through 2029.
– By product, software had the highest share of 65.6% in 2023, and this segment is expected to achieve a CAGR of 30.4% over the forecast period.
– By application, the clinical and molecular diagnostics segment had the highest share of 28.9% in 2023. This segment is expected to grow at a CAGR of 27.6% during the forecast period.
– By end user, the contract research organization segment had the highest share of 64.5% in 2023. This segment is expected to grow at a CAGR of 29.2% during the forecast period.
– In terms of market share, North America was the largest worldwide region in 2023, followed by Europe, Asia-Pacific, and the rest of the world. The North American market is projected to grow at a CAGR of 28.1% over the forecast period.
Frequently Asked Questions (FAQs)
What is the projected market size and growth rate of the Artificial Intelligence (AI) in Life Sciences market?
The global Artificial Intelligence (AI) In Life Sciences market was valued at $8.0 billion in 2023 and is expected to reach $33.5 billion by the end of 2029, expected to grow at a CAGR of 27.9% from 2024 to 2029.
What are the key factors driving the growth of the Artificial Intelligence (AI) in Life Sciences market?
The growth of Artificial Intelligence (AI) in the Life Sciences market is primarily driven by the increasing adoption of AI-driven solutions for drug discovery and development, the rising need for precision medicine and personalized treatment approaches, and the demand for advanced diagnostic tools to analyze complex biological data.
What segments are covered in the global Artificial Intelligence (AI) in Life Sciences market?
The global Artificial Intelligence (AI) market in the Life Sciences is segmented based on product, application, end user, and region.
By Type, which segment will dominate the market by the end of 2029?
The software segment will dominate the market by the end of 2029.
Which region has the highest market share in the Artificial Intelligence (AI) in Life Sciences market?
North America holds the highest share in the market.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Artificial Intelligence in Drug Discovery
Artificial Intelligence in Molecular Diagnostics
Artificial Intelligence in Clinical Diagnostics
Artificial Intelligence in Clinical Trials
Artificial Intelligence in Precision Medicine
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Chapter 4 Emerging Technologies and Developments
Introduction
Clinical Trials
Clinical Trials, by Status
Clinical Trials, by Study
Granted Patents
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis, by Product
Global
Software
Services
Market Analysis, by Application
Market Analysis and Forecast
Drug Discovery
Clinical and Molecular Diagnostics
Clinical Trials
Precision and Personalized Medicine
Market Analysis, by End User
Market Analysis and Forecast
Contract Research Organizations
Research Centers and Academic Institutes
Pharmaceutical and Biotechnology Companies
Geographic Breakdown
Market Analysis, by Region
Global
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Top Players and Products
Strategic Analysis
Mergers and Acquisitions
Funding
Chapter 7 Appendix
Methodology
Sources
Acronyms
Definitions/Taxonomy
Company Profiles
AICURE
APIXIO
ATOMWISE INC.
BENEVOLENTAI
ENLITIC INC.
NUMEDII INC.
RECURSION
ZEBRA TECHNOLOGIES CORP.
List of Tables
Summary Table : Global Market for Artificial Intelligence (AI) in Life Sciences, by Product, Through 2029
Table 1 : Publications Referencing Artificial Intelligence in Life Sciences, 2021–2023
Table 2 : Artificial Intelligence in Life Science Products from Global Players
Table 3 : Different Types of Data Used in the Life Science Industry for Artificial Intelligence
Table 4 : Global Regulatory, Ethical Considerations for Artificial Intelligence in Drug Discovery
Table 5 : Artificial Intelligence in the Life Sciences: Emerging Technologies
Table 6 : Selected Clinical Trial Data for Artificial Intelligence in Life Sciences, 2021-2023
Table 7 : Selected Granted Patents of AI in Life Sciences, 2021-2024
Table 8 : Global Market for AI in Life Sciences, by Product, Through 2029
Table 9 : Global Market for AI in Life Sciences, by Application, Through 2029
Table 10 : Global Market for AI in Life Sciences, by End User, Through 2029
Table 11 : Global Market for AI in Life Sciences, by Region, Through 2029
Table 12 : North American Market for AI in Life Sciences, by Country, Through 2029
Table 13 : North American Market for AI in Life Sciences, by Product, Through 2029
Table 14 : North American Market for AI in Life Sciences, by Application, Through 2029
Table 15 : North American Market for AI in Life Sciences, by End User, Through 2029
Table 16 : European Market for AI in Life Sciences, by Country, Through 2029
Table 17 : European Market for AI in Life Sciences, by Product, Through 2029
Table 18 : European Market for AI in Life Sciences, by Application, Through 2029
Table 19 : European Market for AI in Life Sciences, by End User, Through 2029
Table 20 : Asia-Pacific Market for AI in Life Sciences, by Country, Through 2029
Table 21 : Asia-Pacific Market for AI in Life Sciences, by Product, Through 2029
Table 22 : Asia-Pacific Market for AI in Life Sciences, by Application, Through 2029
Table 23 : Asia-Pacific Market for AI in Life Sciences, by End User, Through 2029
Table 24 : Rest of the World Market for AI in Life Sciences, Through 2029
Table 25 : Rest of the World Market for AI in Life Sciences, by Product, Through 2029
Table 26 : Rest of the World Market for AI in Life Sciences, by Application, Through 2029
Table 27 : Rest of the World Market for AI in Life Sciences, by End User, Through 2029
Table 28 : Top Players and Products in Artificial Intelligence (AI) in Life Science Market
Table 29 : Mergers and Acquisitions in the Global Market for AI in Life Sciences, 2023-2024
Table 30 : Fundings in the Global Market for AI Life Sciences, 2022-2024
Table 31 : Report Information Sources
Table 32 : Major Acronyms Used in This Report
Table 33 : AiCure: Company Snapshot
Table 34 : AiCure: Product Portfolio
Table 35 : AiCure: News/Key Developments, 2024
Table 36 : Apixio: Company Snapshot
Table 37 : Apixio: Product Portfolio
Table 38 : Apixio: News/Key Developments, 2024
Table 39 : Atomwise Inc.: Company Snapshot
Table 40 : Atomwise Inc.: Product Portfolio
Table 41 : Atomwise Inc.: News/Key Developments, 2022
Table 42 : BenevolentAI: Company Snapshot
Table 43 : BenevolentAI: Financial Performance, FY 2022 and 2023
Table 44 : BenevolentAI: Product Portfolio
Table 45 : BenevolentAI: News/Key Developments, 2024
Table 46 : Enlitic Inc.: Company Snapshot
Table 47 : Enlitic Inc.: Financial Performance, FY 2022 and 2023
Table 48 : Enlitic Inc.: Product Portfolio
Table 49 : Enlitic Inc.: News/Key Developments, 2024
Table 50 : NuMedii Inc.: Company Snapshot
Table 51 : NuMedii Inc.: Product Portfolio
Table 52 : NuMedii Inc.: News/Key Developments, 2020
Table 53 : Recursion: Company Snapshot
Table 54 : Recursion: Financial Performance, FY 2022 and 2023
Table 55 : Recursion: Product Portfolio
Table 56 : Recursion: News/Key Developments, 2023-2024
Table 57 : Zebra Technologies Corp.: Company Snapshot
Table 58 : Zebra Technologies Corp.: Financial Performance, FY 2022 and 2023
Table 59 : Zebra Technologies Corp.: Product Portfolio
Table 60 : Zebra Technologies Corp.: News/Key Developments, 2024
List of Figures
Summary Figure : Global Market for Artificial Intelligence (AI) in Life Sciences, by Product, 2021-2029
Figure 1 : Breakdown of Publications Referencing Artificial Intelligence in Life Sciences, 2021-2023
Figure 2 : Market Dynamics of Artificial Intelligence in Life Sciences
Figure 3 : Total Precision Medicine Treatment Spending Worldwide, 2022-2024
Figure 4 : Share of Clinical Trials in Global AI in Life Sciences Market, by Status, 2020-2024
Figure 5 : Share of Clinical Trials in Global AI in Life Sciences Market, by Study, 2020-2024
Figure 6 : Clinical Trials in Global AI in Life Sciences Market, by Interventions, 2020-2024
Figure 7 : Patents Granted for AI in Life Sciences Market, by Year, 2020-2023
Figure 8 : Global Market Shares of AI in Life Sciences, by Product, 2023
Figure 9 : Global Market Shares of AI in Life Sciences, by Application, 2023
Figure 10 : Global Market Shares of AI in Life Sciences, by End User, 2023
Figure 11 : Global Market Shares of AI in Life Sciences, by Region, 2023
Figure 12 : North American Market Shares of AI in Life Sciences, by Country, 2023
Figure 13 : North American Market Shares of AI in Life Sciences, by Product, 2023
Figure 14 : North American Market Shares of AI in Life Sciences, by Application, 2023
Figure 15 : North American Market Shares of AI in Life Sciences, by End User, 2023
Figure 16 : European Market Shares of AI in Life Sciences, by Country, 2023
Figure 17 : European Market Shares of AI in Life Sciences, by Product, 2023
Figure 18 : European Market Shares of AI in Life Sciences, by Application, 2023
Figure 19 : European Market Shares of AI in Life Sciences, by End User, 2023
Figure 20 : Asia-Pacific Market Shares of AI in Life Sciences, by Country, 2023
Figure 21 : Asia-Pacific Market Shares of AI in Life Sciences, by Product, 2023
Figure 22 : Asia-Pacific Market Shares of AI in Life Sciences, by Application, 2023
Figure 23 : Asia-Pacific Market Shares of AI in Life Sciences, by End User, 2023
Figure 24 : Rest of the World Market Shares of AI in Life Sciences, by Product, 2023
Figure 25 : Rest of the World Market Shares of AI in Life Sciences, by Application, 2023
Figure 26 : Rest of the World Market Shares of AI in Life Sciences, by End User, 2023
Figure 27 : BenevolentAI: Revenue Share, by Country/Region, FY 2023
Figure 28 : Enlitic Inc.: Revenue Share, by Business Unit, FY 2023
Figure 29 : Enlitic Inc.: Revenue Share, by Country/Region, FY 2023
Figure 30 : Zebra Technologies Corp.: Revenue Share, by Business Unit, FY 2023
BCC Research(BCCリサーチ)はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
- 免疫療法薬の世界市場 2025-11-12
- 農業におけるAIの世界市場 2025-11-10
- 固体酸化物形燃料電池の技術と世界市場 2025-11-07
- 世界の電気アーク炉市場 2025-11-07